Key result
Symptoms in metabolic syndrome are linked to ~9-fold higher rates of CHD vs. asymptomatic status.
Why the study?
The diagnostic value of exercise stress testing to detect coronary heart disease in patients with metabolic syndrome was uncertain.
Does electrocardiogram exercise stress testing accurately detect coronary heart disease in patients with metabolic syndrome?
Observational (n=2,803)
No
Does electrocardiogram exercise stress testing accurately detect coronary heart disease in patients with metabolic syndrome?
Exercise ECG stress testing has limited diagnostic value for detecting coronary heart disease in patients with metabolic syndrome, though CHD is more prevalent in symptomatic patients.
Answers are grounded in this paper and cite their sources.
Exercise stress testing has limited diagnostic value for CHD in metabolic syndrome; leaves open its role in symptomatic patients pending prospective validation.
Summary Objectives :The aim of this study was to assess the diagnostic value of exercise stress testing to detect coronary heart disease (CHD) in the group of patients with metabolic syndrome. Design and methods : 2803 patients without prior diagnosis of CHD and identified metabolic syndrome were investigated. Subjects underwent electrocardiogram (ECG) stress testing and, depending on the results, coronary angiography and/or coronary computed tomography angiography to detect hemodynamically significant stenosis. CHD was confirmed, if lumen narrowing ≥ 50% of coronary arteries was found. Results : Exercise stress testing was interpreted as positive in 12% patients (71.7% women and 28.3% men). CHD was diagnosed in 45 patients (1.6%), 23 of them had positive exercise stress testing. ECG stress testing was more frequently positive in patients, who had typical/atypical anginal chest pain, dyspnea and/or non-anginal chest pain, in comparison to asymptomatic patients (16.6% vs 8.9%, p <0.001). CHD was more often diagnosed in symptomatic patients compared to patients with no symptoms (6.1% vs 0.7%, p < 0.001, women 5.3% vs 0.6%, p < 0.001, men respectively 8% vs 0.8%, p < 0.001). Conclusions : Diagnostic value of exercise stress testing for detecting CHD is limited in population with metabolic syndrome. CHD was more prevalent in patients with chest pain or dyspnea than in asymptomatic patients.
No takes yet. Share an insight, caveat, or question.
Badarienė et al. (2015) conducted an observational in Metabolic syndrome (n=2,803). Presence of symptoms (chest pain or dyspnea) vs. Asymptomatic patients was evaluated on Diagnosis of coronary heart disease (CHD) (p=<0.001). In patients with metabolic syndrome, coronary heart disease was diagnosed significantly more often in those with symptoms such as chest pain or dyspnea compared to asymptomatic patients (6.1% vs 0.7%, p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: